Skip to content

Clinical trials

Phase 3 Colorectal Neoplasms trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colorectal Neoplasms Phase: Phase 3 Country / region: Norway Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20032
20051
20061
20072
20091
20111
20162
20191
20201
20211
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting4
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer3
European Organisation for Research and Treatment of Cancer - EORTC2
Hoffmann-La Roche2
Anna Martling1
Bristol-Myers Squibb1
Eli Lilly and Company1
Incyte Corporation1
Merck Sharp & Dohme LLC1
Oslo University Hospital1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colorectal Neoplasms17
Colonic Neoplasms4
Rectal Neoplasms3
Neoplasm Metastasis2
Adenoma1
Colonic Diseases1
Digestive System Diseases1
Digestive System Neoplasms1
Gastrointestinal Diseases1
Gastrointestinal Neoplasms1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.